The idea that aging and illness go hand and hand is, of course, nothing new. What’s new is the newfound confidence of scientists that “aging” can be measured, reverse-engineered and controlled.
We’ve all met older adults who seem younger, whose bodies and brains seem decades nimbler than their actual ages, and wondered, “What makes them different?” Despite the wide range of supplements and related products that claim, without scientific evidence, that they can turn back the years, the key to foiling Father Time may lie in the field of epigenetics.
What if we could end aging and prevent age-related diseases? Joseph Pace and guests explore recent advances in aging and longevity research.
Pretreatment with a stem-cell-activating protein significantly enhances healing in mice, Stanford researchers say. The approach could eventually help people going into surgery or combat heal better from injuries they sustain.
Is it real or science fiction to dream of being able to treat… getting old? In this episode, we discuss with Dr. Thomas Rando from Stanford, Kristen Fortney, CEO of BioAge, and a16z’s general partner Vijay Pande where we are in the field of “geroscience” — the idea of studying aging itself, and aging as the root risk for all aging related disease. Far from science fiction, recent discoveries have given us a whole crop of promising breakthroughs to treat aging, such as parabiosis (young blood infused into old blood), senolytics, and rapamycin, and more.